Serodiagnosis of tuberculosis

Area of Science:

• Immunology
• Microbiology
• Medical Diagnostics

Background:

• Conventional tuberculosis diagnosis faces limitations.
• Early serodiagnostic tests for TB had limited utility due to high false positivity with crude antigens.
• Advancements in ELISA techniques using purified antigens have improved diagnostic accuracy.

Purpose of the Study:

• To evaluate the efficacy of serological tests in diagnosing tuberculosis.
• To assess the performance of ELISA using purified mycobacterial antigens and detecting antigens in clinical specimens.
• To explore the potential of serological assays for diagnosing smear-negative tuberculosis.

Main Methods:

• Enzyme-Linked Immunosorbent Assay (ELISA) was employed to detect specific antimycobacterial antibodies and antigens.
• Purified and semi-purified mycobacterial antigens (glycolipid, antigen '5', 38 Kd protein) were used to estimate antibodies.
• Detection of mycobacterial antigens (43 Kd, Lipoarabinomannan, antigen '5') in serum, CSF, and other body fluids was investigated.

Main Results:

• Purified antigens demonstrated improved sensitivity (ST) and specificity (SP): glycolipid antigen (ST 88%, SP 96%), antigen '5' (ST 72%, SP 91%), 38 Kd protein (ST 83%).
• Detection of antigens in clinical specimens showed high performance: 43 Kd antigen, Lipoarabinomannan, and antigen '5' (ST 80-100%, SP 93-100%).
• Serological tests showed significant potential for diagnosing smear-negative tuberculosis.

Conclusions:

• Serological tests utilizing ELISA with purified antigens and antigen detection in body fluids are effective for tuberculosis diagnosis.
• These methods offer rapid, inexpensive, and simple alternatives, especially for smear-negative cases.
• Further development of serological assays can significantly aid in global tuberculosis control efforts.